1-3 of 3
Ute Mark
Close
Sort by
Journal Articles

Reduced Expression of CD62L Is Associated with Increased ADAM17 Activity and Predicts Molecular Response to Nilotinib Therapy in Patients with Early Chronic Phase Chronic Myelogenous Leukemia (CML-CP)

Sieghart Sopper, PhD, Satu Mustjoki, MD PhD, Angelica Loskog, PhD, Bjorn T. Gjertsen, MD PhD, Ute Mark, Jens Haenig, Nidas Jurjonas, Gunther Gastl, Prof., Dr., Frank Giles, MDMB, Andreas Hochhaus, MD, Gert J Ossenkoppele, MD PhD, Kimmo Porkka, MD PhD, Dominik Wolf, MD
Journal: Blood
Blood (2014) 124 (21): 4522.
https://doi.org/10.1182/blood.V124.21.4522.4522
Published: 2014
Journal Articles

Immune Monitoring In Patients With Early Chronic Phase Chronic Myelogenous Leukemia (CML-CP) Treated With Frontline Nilotinib

Sieghart Sopper, PhD, Satu Mustjoki, MD, PhD, Angelica Loskog, PhD, Bjorn T Gjertsen, MD PhD, Richard Greil, MD, Alois Lang, MD, Werner Linkesch, MD, Josef Thaler, MD, Tobias Gedde-Dahl, III, MD, PhD, Henrik Hjorth-Jansen, MD, Waleed Majeed, MD, Kourosh Lofti, MD, PhD, Johan Richter, MD, PhD, Sören Lehman, MD, Leif Stenke, MD, PhD, Ulla Olsson-Strömberg, MD, PhD, Jesper Stentoft, MD, Ward Posthuma, MD, PhD, Willem Smit, Edo Vellenga, MD, PhD, Gregor Verhoef, Augustin Ferrant, MD, PhD, Jan Van Droogenbroeck, MD, Ute Mark, Jens Haenig, Nidas Jurjonas, Gunther Gastl, Prof., Dr., Frank Giles, MD MB, Andreas Hochhaus, MD, Gert J. Ossenkoppele, MD PhD, Kimmo Porkka, MD, PhD, Dominik Wolf, MD
Journal: Blood
Blood (2013) 122 (21): 2731.
https://doi.org/10.1182/blood.V122.21.2731.2731
Published: 2013
Journal Articles

Early PK-Analysis Predicts Molecular Response In Patients With Early Chronic Phase Chronic Myelogenous Leukemia (CML-CP) Treated With Frontline Nilotinib

Dominik Wolf, MD, Jorn Skavland, PhD, Christoph Seger, PhD, Sieghart Sopper, PhD, Wiktor-Wieslaw Jedrzejczak, MD, PhD, Dubravka Sertic, MD, Jaroslava Voglova, MD, Satu Mustjoki, MD PhD, Leif Stenke, MD, PhD, Augustin Ferrant, MD, PhD, Richard Greil, MD, Alois Lang, MD, Josef Thaler, MD, PhD, Werner Linkesch, MD, Antica Duletić-Načinović, MD , PhD, Andrzej Hellmann, MD, PhD, Georgi G. Mihaylov, MD, PhD, Tobias Gedde-Dahl, III, MD, PhD, Henrik Hjorth-Hansen, MD, PhD, Waleed Majeed, MD, Jesper Stentoft, MD, Gregor Verhoef, M.D. Ph.D., Jan Van Droogenbroeck, MD, Ute Mark, Jens Haenig, Nidas Jurjonas, Frank Giles, MD MB, Andreas Hochhaus, MD, Kimmo Porkka, MD, PhD, Gert J. Ossenkoppele, MD PhD, Bjorn T. Gjertsen, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1485.
https://doi.org/10.1182/blood.V122.21.1485.1485
Published: 2013